📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine. (2018)

First Author: Lotery AJ

Attributed to: Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3399/bjgp18x694985

PubMed Identifier: 29472211

Publication URI: http://europepmc.org/abstract/MED/29472211

Type: Journal Article/Review

Volume: 68

Parent Publication: The British journal of general practice : the journal of the Royal College of General Practitioners

Issue: 668

ISSN: 0960-1643